The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review.

Economic evaluations can help decision makers identify what services for children with neurodevelopmental disorders provide best value-for-money. The aim of this paper is to review the best available economic evidence to support decision making for attention deficit-hyperactivity disorder (ADHD) and...

Descripción completa

Detalles Bibliográficos
Publicado en:European Child & Adolescent Psychiatry Vol. 31; no. 11; pp. 1655 - 1671
Autores principales: Sampaio, Filipa, Feldman, Inna, Lavelle, Tara A., Skokauskas, Norbert
Formato: research systematic review tables/charts Journal Article
Publicado: Springer Nature Nov2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160256394&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 160256394
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10188827
        EJ3
      jtl: European Child & Adolescent Psychiatry
      issn: 10188827
      maglogo: N
    pubinfo:
      dt: Nov2022
      vid: 31
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        160256394
        149143924
        160256394
        160256394
        10.1007/s00787-021-01748-z
        160256394
      ppf: 1655
      ppct: 16
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review.
      aug:
        au:
          Sampaio, Filipa
          Feldman, Inna
          Lavelle, Tara A.
          Skokauskas, Norbert
        affil: Department of Public Health and Caring Sciences, Uppsala University, Husargatan 3, P.O Box 564, 751 22, Uppsala, Sweden
      sug:
        subj:
          Attention Deficit Hyperactivity Disorder Therapy
          Attention Deficit Hyperactivity Disorder Therapy
          Autism Spectrum Disorder Therapy
          Autism Spectrum Disorder Therapy
          Cost Benefit Analysis
          Decision Making, Clinical
          Human
          Systematic Review
          Child
          Adolescence
          Medline
          Psycinfo
          ERIC Database
          Checklists
          Behavior Therapy Methods
          Parenting
          Attention Deficit Hyperactivity Disorder Drug Therapy
          Child, Preschool
          Child: 6-12 years
          Adolescent: 13-18 years
          Child, Preschool: 2-5 years
      ab: Economic evaluations can help decision makers identify what services for children with neurodevelopmental disorders provide best value-for-money. The aim of this paper is to review the best available economic evidence to support decision making for attention deficit-hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in children and adolescents. We conducted a systematic review of economic evaluations of ADHD and ASD interventions including studies published 2010–2020, identified through Econlit, Medline, PsychINFO, and ERIC databases. Only full economic evaluations comparing two or more options, considering both costs and consequences were included. The quality of the studies was assessed using the Drummond checklist. We identified ten studies of moderate-to-good quality on the cost-effectiveness of treatments for ADHD and two studies of good quality of interventions for ASD. The majority of ADHD studies evaluated pharmacotherapy (n = 8), and two investigated the economic value of psychosocial/behavioral interventions. Both economic evaluations for ASD investigated early and communication interventions. Included studies support the cost-effectiveness of behavioral parenting interventions for younger children with ADHD. Among pharmacotherapies for ADHD, different combinations of stimulant/non-stimulant medications for children were cost-effective at willingness-to-pay thresholds reported in the original papers. Early intervention for children with suspected ASD was cost-effective, but communication-focused therapy for preschool children with ASD was not. Prioritizing more studies in this area would allow decision makers to promote cost-effective and clinically effective interventions for this target group.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N